NCT07236541 Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study Status RECRUITING Phase N/A
NCT06751069 Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease Status RECRUITING Phase NA
NCT06189820 Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases Status RECRUITING Phase PHASE2
NCT05648734 Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT05516550 Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19 Status UNKNOWN Phase PHASE2/PHASE3
NCT04274257 A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT01570764 Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease Status COMPLETED Phase PHASE3